CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells

被引:32
|
作者
Lehnus, Kristina S. [1 ]
Donovan, Laura K. [1 ]
Huang, Xiaowei [2 ]
Zhao, Ninghui [3 ]
Warr, Tracy J. [4 ]
Pilkington, Geoffrey J. [1 ]
An, Qian [1 ]
机构
[1] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Cellular & Mol Neurooncol Res Grp, Portsmouth PO1 2DT, Hants, England
[2] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China
[3] Kunming Med Coll, Dept Neurosurg, Hosp 2, Kunming, Yunnan, Peoples R China
[4] Wolverhampton Univ, Sch Appl Sci, Res Inst Healthcare Sci, Brain Tumour UK Neurooncol Res Grp, Wolverhampton WV1 1DJ, W Midlands, England
关键词
CD133; cancer stem cell; glycosylation; hypoxia; glioma; PROMININ-1; CD133; OXYGEN-TENSION; CANCER-CELLS; EXPRESSION; METABOLISM; ACTIVATION; EXPANSION; MARKER;
D O I
10.3892/ijo.2013.1787
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cancer stem cell (CSC) marker CD133 is widely expressed in gliomas and employed mostly by use of the CD133/1 antibody which binds the extracellular glycosylated AC133 epitope. CD133 recognition may, however, be affected by its glycosylation pattern and oxygen tension. The present study investigates the effect of oxygen deprivation on CD133 expression and glycosylation status employing a high AC133-expressing glioblastoma multiforme (GBM) cell line, IN699. IN699 cells were cultured under normoxic (21% O-2) and hypoxic (3% O-2) conditions. CD133 expression was analysed by western blotting (WB), qRT-PCR, immunocytochemistry (ICC) and flow cytometry using the glycosylation-specific antibody CD133/1 and ab19898 which binds the unglycosylated intracellular residues of CD133. By flow cytometry, ab19898 detected 94.1% and 96.2% CD133(+) cells under normoxia and hypoxia, respectively. Hypoxia significantly increased the percentage of CD133(+) cells from 69% to 92% using CD133/1 (p<0.005). Moreover, a significantly higher geomean fluorescence intensity (GMI) was demonstrated by ab19898 (p<0.005) in CD133(+) cells. WB and qRT-PCR results were consistent with flow cytometry data. Furthermore, over a period of 72-h incubation under normoxic and hypoxic conditions after autoMACS sorting, an average of 31.8% and 42.2%, respectively, of CD133-negative IN699 cells became positive using CD13311. Our data show that a) previously reported CD133(-) cells may have been misidentified using the glycosylation-specific CD133/1 as constitutive expression of CD133 was detected by the intracellular antibody ab19898; b) hypoxia promotes glycosylation status of CD133, indicating possible involvement of glycosylated CD133 in the process of anti-hypoxia-mediated apoptosis.
引用
收藏
页码:1011 / 1017
页数:7
相关论文
共 50 条
  • [1] CD133 GLYCOSYLATION IS AFFECTED BY HYPOXIA IN CULTURED GLIOMA STEM CELLS
    Lehnus, Kristina S.
    Donovan, Laura K.
    Pilkington, Geoffrey J.
    An, Qian
    [J]. NEURO-ONCOLOGY, 2011, 13 : 1 - 1
  • [2] EPIGENETIC REGULATION OF CD133 BY PROMOTER METHYLATION IN GLIOMA STEM CELLS
    Gopisetty, Gopal
    Sampath, Deepa
    Xu, Jihong
    Colman, Howard
    Puduvalli, Vinay
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 907 - 907
  • [3] CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
    Wang, Jian
    Sakariassen, Per O.
    Tsinkalovsky, Oleg
    Immervoll, Heike
    Boe, Stig Ove
    Svendsen, Agnete
    Prestegarden, Lars
    Rosland, Gro
    Thorsen, Frits
    Stuhr, Linda
    Molven, Anders
    Bjerkvig, Rolf
    Enger, Per O.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (04) : 761 - 768
  • [4] CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
    Yu, Xiazhen
    Lin, Yingjie
    Yan, Xie
    Tian, Qiang
    Li, Linheng
    Lin, Edward H.
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 253 - 259
  • [5] CD133 stem cells in adult human brain
    H. T. Hassan
    X. Zhai
    J. A. Goodacre
    [J]. Journal of Neuro-Oncology, 2008, 89 : 247 - 248
  • [6] CD133 stem cells in adult human brain
    Hassan, H. T.
    Zhai, X.
    Goodacre, J. A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2008, 89 (02) : 247 - 248
  • [7] Prostate Cancer Stem Cells: The Role of CD133
    Yang, Jianhui
    Aljitawi, Omar
    Van Veldhuizen, Peter
    [J]. CANCERS, 2022, 14 (21)
  • [8] Potential mechanisms of CD133 in cancer stem cells
    Jang, Jae-Woo
    Song, Yeonhwa
    Kim, Se-Hyuk
    Kim, Joon
    Seo, Haeng Ran
    [J]. LIFE SCIENCES, 2017, 184 : 25 - 29
  • [9] CD133 hematopoietic stem cells in coronary ischemia
    Laughlin, Mary
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (11) : 1226 - 1227
  • [10] Limits of CD133 as a marker of glioma self-renewing cells
    Clement, Virginie
    Dutoit, Valerie
    Marino, Denis
    Dietrich, Pierre-Yves
    Radovanovic, Ivan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (01) : 244 - 248